1. Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent. (October 2022) Authors: Singh, A.; Singh, V.; Wallis, N.; Elimelech, O.; Oberman, F.; Ramos, A.; Yisraeli, J.; Spiegelman, V.; Sharma, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗